C Zimmermann1, C Baldo, A Molino. 1. Dipartimento di Medicina e Sanità Pubblica, Servizio di Psicologia Medica, Università di Verona, Italy. christa@borgoroma.univr.it
Abstract
PURPOSE: To examine the effects of framing of outcome and probabilities of cancer occurrence on the treatment preference which breast cancer patients indicate for hypothetical patient scenarios. METHODS: A modified version of the Decision Board Instrument (Levine et al. 1992) was administered to 35 breast cancer patients with past ACT experience. Patients expressed their choice regarding ACT for six scenarios which were characterized by either negative or positive framing of outcome and by one of the three levels of probability of recurrence (high, medium, low). RESULTS: The framing had no influence on ACT choices over all three probability levels. The majority chose ACT for high and medium risk and one third switched from ACT to No ACT in the low-risk condition. This switch was statistically significant. CONCLUSION: Hypothetical treatment decisions against ACT occur only when the probability of recurrence is low and the benefit of ACT is small. This finding for patients with past experience of ACT is similar to those reported for other oncological patient groups still in treatment.
PURPOSE: To examine the effects of framing of outcome and probabilities of cancer occurrence on the treatment preference which breast cancerpatients indicate for hypothetical patient scenarios. METHODS: A modified version of the Decision Board Instrument (Levine et al. 1992) was administered to 35 breast cancerpatients with past ACT experience. Patients expressed their choice regarding ACT for six scenarios which were characterized by either negative or positive framing of outcome and by one of the three levels of probability of recurrence (high, medium, low). RESULTS: The framing had no influence on ACT choices over all three probability levels. The majority chose ACT for high and medium risk and one third switched from ACT to No ACT in the low-risk condition. This switch was statistically significant. CONCLUSION: Hypothetical treatment decisions against ACT occur only when the probability of recurrence is low and the benefit of ACT is small. This finding for patients with past experience of ACT is similar to those reported for other oncological patient groups still in treatment.
Authors: Ines Vaz-Luis; Anne O'Neill; Karen Sepucha; Kathy D Miller; Emily Baker; Chau T Dang; Donald W Northfelt; Eric P Winer; George W Sledge; Bryan Schneider; Ann H Partridge Journal: Cancer Date: 2017-03-21 Impact factor: 6.860
Authors: Jeanne S Mandelblatt; Vanessa B Sheppard; Arti Hurria; Gretchen Kimmick; Claudine Isaacs; Kathryn L Taylor; Alice B Kornblith; Anne-Michelle Noone; Gheorghe Luta; Michelle Tallarico; William T Barry; Lisa Hunegs; Robin Zon; Michael Naughton; Eric Winer; Clifford Hudis; Stephen B Edge; Harvey Jay Cohen; Hyman Muss Journal: J Clin Oncol Date: 2010-06-01 Impact factor: 44.544
Authors: Rachel C Shelton; Grace Clarke Hillyer; Dawn L Hershman; Nicole Leoce; Dana H Bovbjerg; Jeanne S Mandelblatt; Lawrence H Kushi; Lois Lamerato; S David Nathanson; Christine B Ambrosone; Alfred I Neugut Journal: Breast Cancer Res Treat Date: 2012-12-22 Impact factor: 4.872